news Archives

Pharma News – 9 July 2020 Updates

Table of Contents Pharma news – 9 July 2020 Mylan gears up to sell its generic version of Remdesivir at […]

Indian Government is reviewing the use of Remdesivir for Covid-19 following reports of liver damage The Union Health Ministry of

1. Hindustan Antibiotic’s moves to explore opportunities in line with self-reliant India Around 70% of the active pharmaceutical ingredients (API)

India plans to reduce the import of API and other raw materials from China The military face-off between India and

USFDA revokes the special status given to Hydroxychloroquine for treating Covid-19 In March 2020, the US[1] president, Donald Trump began

Remdesivir receives approval from the Indian government Gilead Sciences antiviral drug, Remdesivir has grabbed the attention of many countries for